{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:31:26Z","timestamp":1787920286322,"version":"build-2784847793"},"reference-count":108,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care & Pain Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.accpm.2025.101481","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T17:58:13Z","timestamp":1737482293000},"page":"101481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic novelties in acute heart failure and practical perspectives"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-6369","authenticated-orcid":false,"given":"Benjamin","family":"Deniau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayu","family":"Asakage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Gayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9842-962X","authenticated-orcid":false,"given":"Amina","family":"Rakisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2025.101481_bib0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/ejhf.2431","article-title":"Regional differences in precipitating factors of hospitalization for acute heart failure: insights from the REPORT-HF registry","volume":"24","author":"Tromp","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0010","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2214-109X(20)30004-8","article-title":"Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study","volume":"8","author":"Tromp","year":"2020","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.accpm.2025.101481_bib0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.accpm.2025.101481_bib0020","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2025.101481_bib0025","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0030","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0035","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ejhf.566","article-title":"European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions","volume":"18","author":"Crespo-Leiro","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/ejhf.262","article-title":"International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry","volume":"17","author":"Filippatos","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0050","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1161\/CIRCULATIONAHA.105.590091","article-title":"Acute heart failure syndromes: current state and framework for future research","volume":"112","author":"Gheorghiade","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0060","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/eurheartj\/eht393","article-title":"Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry","volume":"34","author":"Sliwa","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0070","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ejhf.2103","article-title":"Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta-regression in the past four decades","volume":"23","author":"Kimmoun","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jchf.2017.09.023","article-title":"Integrative assessment of congestion in heart failure throughout the patient journey","volume":"6","author":"Girerd","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0080","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrcardio.2015.134","article-title":"Pathophysiology and clinical evaluation of acute heart failure","volume":"13","author":"Mentz","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0085","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","article-title":"Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial","volume":"34","author":"Ambrosy","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0090","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ahj.2010.10.041","article-title":"Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure","volume":"161","author":"Abraham","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0095","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0100","first-page":"208","article-title":"Can natriuretic peptides be used to guide therapy?","volume":"27","author":"Bayes-Genis","year":"2016","journal-title":"EJIFCC"},{"key":"10.1016\/j.accpm.2025.101481_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2014.05.007","article-title":"Rationale and design of the GUIDE-IT study: guiding evidence based therapy using biomarker intensified treatment in heart failure","volume":"2","author":"Felker","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0110","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2009.02.058","article-title":"Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure","volume":"53","author":"Cohen-Solal","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0115","doi-asserted-by":"crossref","first-page":"ehad617","DOI":"10.1093\/eurheartj\/ehad617","article-title":"Acute heart failure: current pharmacological treatment and perspectives","volume":"44","author":"Deniau","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0120","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nrcardio.2017.56","article-title":"Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure","volume":"14","author":"Price","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jchf.2019.07.008","article-title":"Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short- and long-term outcomes","volume":"7","author":"Platz","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0130","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jchf.2021.05.008","article-title":"Lung ultrasound-guided emergency department management of acute heart failure (BLUSHED-AHF): a randomized controlled pilot trial","volume":"9","author":"Pang","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/acem.12878","article-title":"Diagnosing acute heart failure in the emergency department: a systematic review and meta-analysis","volume":"23","author":"Martindale","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jjcc.2023.08.003","article-title":"The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission","volume":"83","author":"Harrison","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0145","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.echo.2014.06.002","article-title":"Precision of echocardiographic estimates of right atrial pressure in patients with acute decompensated heart failure","volume":"27","author":"Tsutsui","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.accpm.2025.101481_bib0150","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0155","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.118.035509","article-title":"Prospective validation of the emergency heart failure mortality risk grade for acute heart failure","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0160","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-156-11-201206050-00003","article-title":"Prediction of heart failure mortality in emergent care: a cohort study","volume":"156","author":"Lee","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0165","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCHEARTFAILURE.114.001460","article-title":"Ischemic electrocardiographic abnormalities and prognosis in decompensated heart failure","volume":"7","author":"Greig","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa2211680","article-title":"Trial of an intervention to improve acute heart failure outcomes","volume":"388","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0175","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.accpm.2025.101481_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2587","article-title":"Acetazolamide in decompensated heart failure with volume overload trial (ADVOR): baseline characteristics","volume":"24","author":"Mullens","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.122.062486","article-title":"Decongestion with acetazolamide in acute decompensated heart failure across the spectrum of left ventricular ejection fraction: a prespecified analysis from the ADVOR trial","volume":"147","author":"Martens","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.accpm.2025.101481_bib0190","first-page":"ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ejhf.2708","article-title":"Association of time-to-intravenous furosemide with mortality in acute heart failure: data from REPORT-HF","volume":"25","author":"Ouwerkerk","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0205","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jchf.2019.01.007","article-title":"Natriuretic response is highly variable and associated with 6-month survival: insights from the ROSE-AHF trial","volume":"7","author":"Hodson","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0220","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/ejhf.1753","article-title":"Clinical importance of urinary sodium excretion in acute heart failure","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ejhf.2397","article-title":"Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction","volume":"24","author":"Tomasoni","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0235","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jacc.2022.07.021","article-title":"Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction","volume":"80","author":"Cunningham","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0245","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","article-title":"Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial","volume":"44","author":"Biegus","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0250","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/jama.2020.19378","article-title":"Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure: the ELISABETH randomized clinical trial","volume":"324","author":"Freund","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0255","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2019.18598","article-title":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial","volume":"322","author":"Kozhuharov","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0260","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1093\/eurheartj\/ehu235","article-title":"Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure","volume":"35","author":"Jankowska","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0265","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ejhf.513","article-title":"Iron deficiency and risk of early readmission following a hospitalization for acute heart failure","volume":"18","author":"N\u00fa\u00f1ez","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0270","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2025.101481_bib0275","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2025.101481_bib0280","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1001\/jama.290.22.2985","article-title":"Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema","volume":"290","author":"Girou","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0285","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00134-011-2311-4","article-title":"CPAP for acute cardiogenic pulmonary oedema from out-of-hospital to cardiac intensive care unit: a randomised multicentre study","volume":"37","author":"Ducros","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0290","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1093\/eurheartj\/ehm502","article-title":"A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects","volume":"28","author":"Plaisance","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0295","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00134-008-1354-7","article-title":"Is helmet CPAP first line pre-hospital treatment of presumed severe acute pulmonary edema?","volume":"35","author":"Foti","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0300","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00003246-199704000-00011","article-title":"Randomized, prospective trial of bilevel versus continuous positive airway pressure in acute pulmonary edema","volume":"25","author":"Mehta","year":"1997","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0305","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0735-1097(00)00785-3","article-title":"High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema","volume":"36","author":"Sharon","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4187\/respcare.01049","article-title":"Patient-ventilator interaction during noninvasive ventilation","volume":"56","author":"Hess","year":"2011","journal-title":"Respir Care"},{"key":"10.1016\/j.accpm.2025.101481_bib0315","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00134-006-0301-8","article-title":"Patient-ventilator asynchrony during assisted mechanical ventilation","volume":"32","author":"Thille","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0320","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00134-009-1416-5","article-title":"Patient-ventilator asynchrony during non-invasive ventilation for acute respiratory failure: a multicenter study","volume":"35","author":"Vignaux","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehx580","article-title":"Indications and practical approach to non-invasive ventilation in acute heart failure","volume":"39","author":"Masip","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0330","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2016.14194","article-title":"Effect of postextubation high-flow nasal cannula vs noninvasive ventilation on reintubation and postextubation respiratory failure in high-risk patients: a randomized clinical trial","volume":"316","author":"Hern\u00e1ndez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0335","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jama.2016.2711","article-title":"Effect of postextubation high-flow nasal cannula vs conventional oxygen therapy on reintubation in low-risk patients: a randomized clinical trial","volume":"315","author":"Hern\u00e1ndez","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0340","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/ejhf.2602","article-title":"Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial","volume":"24","author":"Dom\u00ednguez-Rodr\u00edguez","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0345","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/17482941.2011.575165","article-title":"Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes","volume":"13","author":"Iakobishvili","year":"2011","journal-title":"Acute Card Care"},{"key":"10.1016\/j.accpm.2025.101481_bib0350","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.chest.2017.03.037","article-title":"Morphine use in the ED and outcomes of patients with acute heart failure: a propensity score-matching analysis based on the EAHFE registry","volume":"152","author":"Mir\u00f3","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.accpm.2025.101481_bib0355","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2019.06.015","article-title":"Adverse dose-dependent effects of morphine therapy in acute heart failure","volume":"293","author":"Caspi","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0360","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jchf.2018.03.006","article-title":"Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction","volume":"6","author":"Tsao","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0365","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","article-title":"The vulnerable phase after hospitalization for heart failure","volume":"12","author":"Greene","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0370","first-page":"30","article-title":"Targeting the \u201cvulnerable\u201d period - first 3-6 months after an acute heart failure admission - the light gets brighter","volume":"5","author":"Cotter","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0375","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.122.059725","article-title":"Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial","volume":"146","author":"Kosiborod","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0380","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/CIRCULATIONAHA.118.039331","article-title":"Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril\/valsartan or enalapril in the PIONEER-HF trial","volume":"139","author":"Morrow","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0385","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0390","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(08)60878-8","article-title":"An estimation of the global volume of surgery: a modelling strategy based on available data","volume":"372","author":"Weiser","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2025.101481_bib0395","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.accpm.2025.101481_bib0400","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bjaceaccp\/mkn028","article-title":"Heart failure: pathophysiology, risk assessment, community management and anaesthesia","volume":"8","author":"Kotz\u00e9","year":"2008","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.accpm.2025.101481_bib0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.hfc.2015.07.005","article-title":"Characteristics of intensive care in patients hospitalized for heart failure in Europe","volume":"11","author":"Chioncel","year":"2015","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.accpm.2025.101481_bib0410","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ccl.2024.02.005","article-title":"Acute heart failure: from the emergency department to the intensive care unit","volume":"42","author":"Sheehan","year":"2024","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.accpm.2025.101481_bib0415","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","article-title":"Ultrafiltration in decompensated heart failure with cardiorenal syndrome","volume":"367","author":"Bart","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0420","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jacc.2006.07.073","article-title":"Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure","volume":"49","author":"Costanzo","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0425","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cardfail.2009.12.009","article-title":"Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD","volume":"16","author":"Costanzo","year":"2010","journal-title":"J Card Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0430","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/17482940802262376","article-title":"The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study","volume":"10","author":"Rossinen","year":"2008","journal-title":"Acute Card Care"},{"key":"10.1016\/j.accpm.2025.101481_bib0435","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-1048","article-title":"A review of the management of patients with advanced heart failure in the intensive care unit","volume":"8","author":"Cheshire","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0440","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.2021.18323","article-title":"Cardiogenic shock after acute myocardial infarction: a review","volume":"326","author":"Samsky","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0445","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0450","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"22","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0455","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.accpm.2025.101481_bib0465","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.mayocp.2022.12.007","article-title":"Cardiogenic shock classification and associated mortality risk","volume":"98","author":"Hill","year":"2023","journal-title":"Mayo Clinic Proc"},{"key":"10.1016\/j.accpm.2025.101481_bib0470","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020085","article-title":"Phenotyping cardiogenic shock","volume":"10","author":"Zweck","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.accpm.2025.101481_bib0475","first-page":"52","article-title":"Experts\u2019 recommendations for the management of adult patients with cardiogenic shock","volume":"5","author":"Levy","year":"2015","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.accpm.2025.101481_bib0480","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0485","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.285.2.190","article-title":"One-year survival following early revascularization for cardiogenic shock","volume":"285","author":"Hochman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0490","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13613-024-01260-y","article-title":"Management of cardiogenic shock: a narrative review","volume":"14","author":"Laghlam","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.accpm.2025.101481_bib0495","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.accpm.2025.101481_bib0500","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2025.101481_bib0505","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"11","author":"Uhlig","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.accpm.2025.101481_bib0510","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0515","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/CCM.0b013e318232962a","article-title":"Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies","volume":"40","author":"Landoni","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0520","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","article-title":"Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE","volume":"11","author":"Mebazaa","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.accpm.2025.101481_bib0525","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1161\/CIR.0000000000001076","article-title":"Escalating and de-escalating temporary mechanical circulatory support in cardiogenic shock: a scientific statement from the American Heart Association","volume":"146","author":"Geller","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.accpm.2025.101481_bib0530","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2025.101481_bib0535","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2025.101481_bib0540","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCULATIONAHA.118.038201","article-title":"Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II Trial","volume":"139","author":"Thiele","year":"2019","journal-title":"Circulation"}],"container-title":["Anaesthesia Critical Care & Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235255682500013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235255682500013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T11:06:34Z","timestamp":1744542394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235255682500013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":108,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S235255682500013X"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2025.101481","relation":{},"ISSN":["2352-5568"],"issn-type":[{"value":"2352-5568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic novelties in acute heart failure and practical perspectives","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2025.101481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise d'Anesth\u00e9sie et de R\u00e9animation (SFAR).","name":"copyright","label":"Copyright"}],"article-number":"101481"}}